LEADER 00611nam0-22002291i-450- 001 990001308220403321 035 $a000130822 035 $aFED01000130822 035 $a(Aleph)000130822FED01 035 $a000130822 100 $a20000920d--------km-y0itay50------ba 101 1 $aeng 200 1 $aKonstruktionen und approximationen.$fvon VAHLEN T. 700 1$aVahlen,$bTheodor$059266 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990001308220403321 952 $a222-F-3$b0678$fMA1 959 $aMA1 996 $aKonstruktionen und approximationen$9383608 997 $aUNINA DB $aING01 LEADER 00928nam0 22002531i 450 001 UON00052070 005 20231205102230.263 100 $a20020107d1987 |0itac50 ba 101 $achi 102 $aUN 105 $a||||p ||||| 200 1 $aBan qiao zaji$fYu Huai 210 $a[s.l.]$cJiangsu Wenyi$d1987 215 $a63 p.$d17 cm 606 $aLETTERATURA CINESE$xDINASTIA QING (1644-1911)$xCRITICA$3UONC014094$2FI 686 $aCIN VI A$cCINA - LETTERATURA CLASSICA (FINO AL 1911)$2A 700 0$aYU Huai$3UONV032978$0651427 712 $aJiangsu Wenyi$3UONV254174$4650 801 $aIT$bSOL$c20240220$gRICA 899 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$2UONSI 912 $aUON00052070 950 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$dSI CIN VI A 163 N $eSI SA 94711 7 163 N 996 $aBan qiao zaji$91145380 997 $aUNIOR LEADER 03088oam 2200625zu 450 001 9910219976803321 005 20240318141554.0 010 $a0-8330-6002-3 035 $a(CKB)3170000000065101 035 $a(SSID)ssj0000597644 035 $a(PQKBManifestationID)12256895 035 $a(PQKBTitleCode)TC0000597644 035 $a(PQKBWorkID)10577852 035 $a(PQKB)10895731 035 $a(oapen)doab114988 035 $a(EXLCZ)993170000000065101 100 $a20160829d2007 uy 101 0 $aeng 135 $aurmn|---annan 181 $ctxt 182 $cc 183 $acr 200 00$aAssessment of the AHRQ patient safety initiative : moving from research to practice evaluation report II (2003-2004 210 $cRAND Corporation$d2007 210 31$a[Place of publication not identified]$cRAND Health$d2007 215 $a1 online resource 225 0 $aTechnical report Assessment of the AHRQ patient safety initiative 300 $aBibliographic Level Mode of Issuance: Monograph 311 08$a0-8330-4148-7 327 $aIntroduction -- Context and input evaluations -- Process evaluation: monitoring progress and maintaining vigilance -- Process evaluation: patient safety epidemiology: effective practices and tools -- Process evaluation: building infrastructure for effective practices -- Process evaluation: achieving broader adoption of effective practices -- Product evaluation: selection of outcome measures. 330 $aUpdates the policy context of the Agency for Healthcare Research and Quality (AHRQ) patient safety initiative; documents the priorities and activities being undertaken; lays out an evaluation framework and possible measures of the effects on patient outcomes and on stakeholders other than patients. Discusses implications of the findings for future AHRQ policy, programming, and research; suggests ways to strengthen AHRQ activities. 517 0 $aAssessment of the Agency for Healthcare Research and Quality patient safety initiative 606 $aMedical errors$xPrevention$xGovernment policy$zUnited States 606 $aIatrogenic diseases$xPrevention$xGovernment policy$zUnited States 606 $aPatients$xSafety measures$zUnited States 606 $aMedical Errors$xprevention & control 606 $aProgram Evaluation 606 $aGovernment Programs 607 $aUnited States 615 0$aMedical errors$xPrevention$xGovernment policy 615 0$aIatrogenic diseases$xPrevention$xGovernment policy 615 0$aPatients$xSafety measures 615 12$aMedical Errors$xprevention & control. 615 22$aProgram Evaluation. 615 22$aGovernment Programs. 676 $a610.28/9 702 $aFarley$b Donna 712 02$aUnited States Agency for Healthcare Research and Quality 712 02$aRand Corporation, 712 02$aUnited States 801 0$bPQKB 906 $aBOOK 912 $a9910219976803321 996 $aAssessment of the AHRQ patient safety initiative : moving from research to practice evaluation report II (2003-2004$92872826 997 $aUNINA